FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 51 through 100 of 282

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
CASI Nasdaq CASI Pharmaceuticals, Inc. 2830
CCCC Nasdaq C4 Therapeutics, Inc. 2830
CDT Nasdaq CDT Equity Inc. 2830
CDTX Nasdaq Cidara Therapeutics, Inc. 2830
CGC Nasdaq Canopy Growth Corporation 2830
CGEM Nasdaq Cullinan Therapeutics, Inc. 2830
CGEN Nasdaq Compugen Ltd. 2830
CHGCY Over the counter Chugai Pharmaceutical Co., Ltd. 2830
CHRS Nasdaq Coherus Oncology, Inc. 2830
CLLS Nasdaq Cellectis S.A. 2830
CLRB Nasdaq Cellectar Biosciences, Inc. 2830
CLSD Nasdaq Clearside Biomedical, Inc. 2830
CLVLY Over the counter Clinuvel Pharmaceuticals Limited 2830
CLYM Nasdaq Climb Bio, Inc. 2830
CMND Nasdaq Clearmind Medicine Inc. 2830
CNTX Nasdaq Context Therapeutics Inc. 2830
COLL Nasdaq Collegium Pharmaceutical, Inc. 2830
CPIX Nasdaq Cumberland Pharmaceuticals Inc. 2830
CRBP Nasdaq Corbus Pharmaceuticals Holdings, Inc. 2830
CRBU Nasdaq Caribou Biosciences, Inc. 2830
CRDL Nasdaq Cardiol Therapeutics Inc. 2830
CRL New York Charles River Laboratories International 2830
CRMD Nasdaq CorMedix Inc. 2830
CRON Nasdaq Cronos Group Inc. 2830
CRSP Nasdaq CRISPR Therapeutics AG 2830
CTMX Nasdaq CytomX Therapeutics, Inc. 2830
CTNM Nasdaq Contineum Therapeutics, Inc. 2830
CTOR Nasdaq Citius Oncology, Inc. 2830
CUE Nasdaq Cue Biopharma, Inc. 2830
CURX Nasdaq Curanex Pharmaceuticals Inc 2830
CVKD Nasdaq Cadrenal Therapeutics, Inc. 2830
CYCC Nasdaq Cyclacel Pharmaceuticals, Inc. 2830
CYCN Nasdaq Cyclerion Therapeutics, Inc. 2830
CYTK Nasdaq Cytokinetics, Incorporated 2830
DNLI Nasdaq Denali Therapeutics Inc. 2830
DSNKY Over the counter Daiichi Sankyo Company, Limited 2830
DVAX Nasdaq Dynavax Technologies Corporation 2830
DYAI Nasdaq Dyadic International, Inc. 2830
EDSA Nasdaq Edesa Biotech, Inc. 2830
ELDN Nasdaq Eledon Pharmaceuticals, Inc. 2830
ENGN Nasdaq enGene Holdings Inc. 2830
ENLV Nasdaq Enlivex Therapeutics Ltd. 2830
ENSC Nasdaq Ensysce Biosciences, Inc. 2830
ENTO Nasdaq Entero Therapeutics, Inc. 2830
EOLS Nasdaq Evolus, Inc. 2830
ESAIY Over the counter Eisai Co., Ltd. 2830
ETHZ Nasdaq ETHZilla Corporation 2830
EVGN Nasdaq Evogene Ltd. 2830
EVO Nasdaq Evotec SE 2830
EVOK Nasdaq Evoke Pharma, Inc. 2830
Results 50 through 100 of 282